ERP korelati placebo i 'anti-placebo' efekata
ERP correlates of placebo and 'anti-placebo' effects
Abstract
U ovom istraživanju bavili smo se neuralnim korelatima efekata placebo i 'anti-placebo' poruka putem merenja moždanih talasa (ERP). Umjesto uobičajenog termina nocebo, koristili smo termin 'anti-placebo', budući da poruke koje smo zadavali ispitanicima nisu trebale da proizvedu negativne efekte, već da umanje ili ponište efekat placeba. Primenili smo termalnu draž intenziteta 45 stepeni Celzijusa na kožu podlaktice. Ukupno je 29 studenata uzelo učešća u četiri eksperimentalne situacije: bez analgezije, nakon primene analgezije (korišćenjem EMLA kreme), nakon primene neutralne kreme koja je prezentovana kao analgetik (placebo situacija) i nakon primene EMLA kreme koja je prezentovana kao herbalna krema koja nije zvanično prihvaćena kao medikament ('anti-placebo' situacija). Neposredno nakon stimulacije, od ispitanika je zatraženo da procene nivo neprijatnosti na subjektivnoj skali osetljivosti 1-10, a nakon toga im je zadat kognitivni eksperiment, tokom koga su mereni ERP odgovori. Rezu...ltati su pokazali tri glavna ERP efekta. U ranom efektu, sve tri eksperimentalne situacije koje su podrazumevale primenu anelgezije (tj. dve situacije sa farmako-anelgezijom + situacija sa placebo-aneglezijom) pokazale su različite profile ERP efekata u odnosu na situaciju u kojoj nije primenjena anelgezija. Ovaj rezultat smo interpretirali kao rano očekivanje da bilo koja vrsta anelgezije (uključujući placebo) treba da proizvede nekakav efekat, za razliku od situacije u kojoj nije bilo primene analgezije. Središnji ERP efekat je demonstrirao duže trajanje ERP efekata u situaciji sa 'anti-placebom' i u situaciji bez analgezije, dok su u situaciji sa primenom analgezije i u placebo situaciji ovi efekti bili mnogo kraci. Ovaj nas je rezultat naveo na zaključak da, na neuralnom planu, sugerisanje da je neki lek 'anti-placebo' proizvodi sličan profil ERP ili sličnu mentalnu aktivnost kao u situaciji bez leka. Ovaj rezultat poziva na preispitivanje preporuka lekara da neki lekovi nisu baš dobri, jer ovakve sugestije mogu potencijalno i nesvesno da umanje inače pozitivan efekat koji placebo ima tokom tretmana. Na kraju, u poznom efektu smo takođe uočili razlike između četiri eksperimentalne situacije, ali su ove razlike u vezi sa redosledom izlaganja eksperimentalnih situacija, te smo ih interpretirali kao artefakt eksperimentalnog dizajna.
In the study we observed the effects of placebo and ''anti-placebo' messages on the neural activities registered through the event related potentials (ERP). Instead of commonly used term nocebo, we used the term 'anti-placebo', given that the message we delivered was not supposed to induce the negative effects, but just to diminish the effect of placebo. Thermal stimulus of 45 degrees of Celsius was applied on the skin of 29 students in a four different experimental situations: without analgesia, after receiving dermal analgesic EMLA Cream, after receiving neutral skin cream presented as an analgesic (placebo situation), and after receiving again EMLA Cream, but presented as the herbal analgesic not officially accepted as a medicament ('anti-placebo' situation). Immediately after stimulation, participants were asked to estimate the level of 'unpleasantness' of the stimuli on the subjective scale ranging from 1-10, and to start a cognitive experiment, during which the ERP responses were... measured. Results showed three main ERP effects. In the early effect, we noticed that all three experimental situations with analgesia (that is, two conditions with the pharmaco-analgesia + the condition with the placebo analgesia) showed a different ERP effects in comparison to the condition with no analgesia. We interpreted these results as early expectancies that any analgesic (including placebo) should produce some effect in comparison to no-analgesic condition. In the medium effect, we observed significantly longer durations of the ERP effects in the situation of the 'anti-placebo' and no-analgesia, whereas in the analgesia and placebo condition these effects were much shorter. This result led us to the conclusion, that on the neural level, our suggestion of 'bad medicament' (similar to situation of no-medicament) caused a specific mental activity registered on ERP This effect is the one which calls into a question doctors' recommendations (which contain negative connotation) of medicaments, as they could potentially and unconsciously diminish a valuable impact that the placebo could have during a treatment. Finally, in the late effect, we also observed significant differences across the four experimental conditions, but these differences were directly correspondent with the order of presentation of experimental situations, and we interpret them as an artefact of the experimental design.
Keywords:
toplotni stimulus / placebo / ERP / analgetici / thermal stimulus / placebo / ERP / analgesicsSource:
Primenjena psihologija, 2013, 6, 4, 339-354Publisher:
- Univerzitet u Novom Sadu - Filozofski fakultet - Odsek za psihologiju, Novi Sad
Funding / projects:
- Psychological foundations of mental health: hereditary and environmental factors (RS-MESTD-Basic Research (BR or ON)-179006)
Institution/Community
Psihologija / PsychologyTY - JOUR AU - Biro, Mikloš AU - Ković, Vanja AU - Novović, Zdenka AU - Pejović, Jovana AU - Sokić, Jelena AU - Sovilj, Platon PY - 2013 UR - http://reff.f.bg.ac.rs/handle/123456789/1711 AB - U ovom istraživanju bavili smo se neuralnim korelatima efekata placebo i 'anti-placebo' poruka putem merenja moždanih talasa (ERP). Umjesto uobičajenog termina nocebo, koristili smo termin 'anti-placebo', budući da poruke koje smo zadavali ispitanicima nisu trebale da proizvedu negativne efekte, već da umanje ili ponište efekat placeba. Primenili smo termalnu draž intenziteta 45 stepeni Celzijusa na kožu podlaktice. Ukupno je 29 studenata uzelo učešća u četiri eksperimentalne situacije: bez analgezije, nakon primene analgezije (korišćenjem EMLA kreme), nakon primene neutralne kreme koja je prezentovana kao analgetik (placebo situacija) i nakon primene EMLA kreme koja je prezentovana kao herbalna krema koja nije zvanično prihvaćena kao medikament ('anti-placebo' situacija). Neposredno nakon stimulacije, od ispitanika je zatraženo da procene nivo neprijatnosti na subjektivnoj skali osetljivosti 1-10, a nakon toga im je zadat kognitivni eksperiment, tokom koga su mereni ERP odgovori. Rezultati su pokazali tri glavna ERP efekta. U ranom efektu, sve tri eksperimentalne situacije koje su podrazumevale primenu anelgezije (tj. dve situacije sa farmako-anelgezijom + situacija sa placebo-aneglezijom) pokazale su različite profile ERP efekata u odnosu na situaciju u kojoj nije primenjena anelgezija. Ovaj rezultat smo interpretirali kao rano očekivanje da bilo koja vrsta anelgezije (uključujući placebo) treba da proizvede nekakav efekat, za razliku od situacije u kojoj nije bilo primene analgezije. Središnji ERP efekat je demonstrirao duže trajanje ERP efekata u situaciji sa 'anti-placebom' i u situaciji bez analgezije, dok su u situaciji sa primenom analgezije i u placebo situaciji ovi efekti bili mnogo kraci. Ovaj nas je rezultat naveo na zaključak da, na neuralnom planu, sugerisanje da je neki lek 'anti-placebo' proizvodi sličan profil ERP ili sličnu mentalnu aktivnost kao u situaciji bez leka. Ovaj rezultat poziva na preispitivanje preporuka lekara da neki lekovi nisu baš dobri, jer ovakve sugestije mogu potencijalno i nesvesno da umanje inače pozitivan efekat koji placebo ima tokom tretmana. Na kraju, u poznom efektu smo takođe uočili razlike između četiri eksperimentalne situacije, ali su ove razlike u vezi sa redosledom izlaganja eksperimentalnih situacija, te smo ih interpretirali kao artefakt eksperimentalnog dizajna. AB - In the study we observed the effects of placebo and ''anti-placebo' messages on the neural activities registered through the event related potentials (ERP). Instead of commonly used term nocebo, we used the term 'anti-placebo', given that the message we delivered was not supposed to induce the negative effects, but just to diminish the effect of placebo. Thermal stimulus of 45 degrees of Celsius was applied on the skin of 29 students in a four different experimental situations: without analgesia, after receiving dermal analgesic EMLA Cream, after receiving neutral skin cream presented as an analgesic (placebo situation), and after receiving again EMLA Cream, but presented as the herbal analgesic not officially accepted as a medicament ('anti-placebo' situation). Immediately after stimulation, participants were asked to estimate the level of 'unpleasantness' of the stimuli on the subjective scale ranging from 1-10, and to start a cognitive experiment, during which the ERP responses were measured. Results showed three main ERP effects. In the early effect, we noticed that all three experimental situations with analgesia (that is, two conditions with the pharmaco-analgesia + the condition with the placebo analgesia) showed a different ERP effects in comparison to the condition with no analgesia. We interpreted these results as early expectancies that any analgesic (including placebo) should produce some effect in comparison to no-analgesic condition. In the medium effect, we observed significantly longer durations of the ERP effects in the situation of the 'anti-placebo' and no-analgesia, whereas in the analgesia and placebo condition these effects were much shorter. This result led us to the conclusion, that on the neural level, our suggestion of 'bad medicament' (similar to situation of no-medicament) caused a specific mental activity registered on ERP This effect is the one which calls into a question doctors' recommendations (which contain negative connotation) of medicaments, as they could potentially and unconsciously diminish a valuable impact that the placebo could have during a treatment. Finally, in the late effect, we also observed significant differences across the four experimental conditions, but these differences were directly correspondent with the order of presentation of experimental situations, and we interpret them as an artefact of the experimental design. PB - Univerzitet u Novom Sadu - Filozofski fakultet - Odsek za psihologiju, Novi Sad T2 - Primenjena psihologija T1 - ERP korelati placebo i 'anti-placebo' efekata T1 - ERP correlates of placebo and 'anti-placebo' effects EP - 354 IS - 4 SP - 339 VL - 6 UR - https://hdl.handle.net/21.15107/rcub_reff_1711 ER -
@article{ author = "Biro, Mikloš and Ković, Vanja and Novović, Zdenka and Pejović, Jovana and Sokić, Jelena and Sovilj, Platon", year = "2013", abstract = "U ovom istraživanju bavili smo se neuralnim korelatima efekata placebo i 'anti-placebo' poruka putem merenja moždanih talasa (ERP). Umjesto uobičajenog termina nocebo, koristili smo termin 'anti-placebo', budući da poruke koje smo zadavali ispitanicima nisu trebale da proizvedu negativne efekte, već da umanje ili ponište efekat placeba. Primenili smo termalnu draž intenziteta 45 stepeni Celzijusa na kožu podlaktice. Ukupno je 29 studenata uzelo učešća u četiri eksperimentalne situacije: bez analgezije, nakon primene analgezije (korišćenjem EMLA kreme), nakon primene neutralne kreme koja je prezentovana kao analgetik (placebo situacija) i nakon primene EMLA kreme koja je prezentovana kao herbalna krema koja nije zvanično prihvaćena kao medikament ('anti-placebo' situacija). Neposredno nakon stimulacije, od ispitanika je zatraženo da procene nivo neprijatnosti na subjektivnoj skali osetljivosti 1-10, a nakon toga im je zadat kognitivni eksperiment, tokom koga su mereni ERP odgovori. Rezultati su pokazali tri glavna ERP efekta. U ranom efektu, sve tri eksperimentalne situacije koje su podrazumevale primenu anelgezije (tj. dve situacije sa farmako-anelgezijom + situacija sa placebo-aneglezijom) pokazale su različite profile ERP efekata u odnosu na situaciju u kojoj nije primenjena anelgezija. Ovaj rezultat smo interpretirali kao rano očekivanje da bilo koja vrsta anelgezije (uključujući placebo) treba da proizvede nekakav efekat, za razliku od situacije u kojoj nije bilo primene analgezije. Središnji ERP efekat je demonstrirao duže trajanje ERP efekata u situaciji sa 'anti-placebom' i u situaciji bez analgezije, dok su u situaciji sa primenom analgezije i u placebo situaciji ovi efekti bili mnogo kraci. Ovaj nas je rezultat naveo na zaključak da, na neuralnom planu, sugerisanje da je neki lek 'anti-placebo' proizvodi sličan profil ERP ili sličnu mentalnu aktivnost kao u situaciji bez leka. Ovaj rezultat poziva na preispitivanje preporuka lekara da neki lekovi nisu baš dobri, jer ovakve sugestije mogu potencijalno i nesvesno da umanje inače pozitivan efekat koji placebo ima tokom tretmana. Na kraju, u poznom efektu smo takođe uočili razlike između četiri eksperimentalne situacije, ali su ove razlike u vezi sa redosledom izlaganja eksperimentalnih situacija, te smo ih interpretirali kao artefakt eksperimentalnog dizajna., In the study we observed the effects of placebo and ''anti-placebo' messages on the neural activities registered through the event related potentials (ERP). Instead of commonly used term nocebo, we used the term 'anti-placebo', given that the message we delivered was not supposed to induce the negative effects, but just to diminish the effect of placebo. Thermal stimulus of 45 degrees of Celsius was applied on the skin of 29 students in a four different experimental situations: without analgesia, after receiving dermal analgesic EMLA Cream, after receiving neutral skin cream presented as an analgesic (placebo situation), and after receiving again EMLA Cream, but presented as the herbal analgesic not officially accepted as a medicament ('anti-placebo' situation). Immediately after stimulation, participants were asked to estimate the level of 'unpleasantness' of the stimuli on the subjective scale ranging from 1-10, and to start a cognitive experiment, during which the ERP responses were measured. Results showed three main ERP effects. In the early effect, we noticed that all three experimental situations with analgesia (that is, two conditions with the pharmaco-analgesia + the condition with the placebo analgesia) showed a different ERP effects in comparison to the condition with no analgesia. We interpreted these results as early expectancies that any analgesic (including placebo) should produce some effect in comparison to no-analgesic condition. In the medium effect, we observed significantly longer durations of the ERP effects in the situation of the 'anti-placebo' and no-analgesia, whereas in the analgesia and placebo condition these effects were much shorter. This result led us to the conclusion, that on the neural level, our suggestion of 'bad medicament' (similar to situation of no-medicament) caused a specific mental activity registered on ERP This effect is the one which calls into a question doctors' recommendations (which contain negative connotation) of medicaments, as they could potentially and unconsciously diminish a valuable impact that the placebo could have during a treatment. Finally, in the late effect, we also observed significant differences across the four experimental conditions, but these differences were directly correspondent with the order of presentation of experimental situations, and we interpret them as an artefact of the experimental design.", publisher = "Univerzitet u Novom Sadu - Filozofski fakultet - Odsek za psihologiju, Novi Sad", journal = "Primenjena psihologija", title = "ERP korelati placebo i 'anti-placebo' efekata, ERP correlates of placebo and 'anti-placebo' effects", pages = "354-339", number = "4", volume = "6", url = "https://hdl.handle.net/21.15107/rcub_reff_1711" }
Biro, M., Ković, V., Novović, Z., Pejović, J., Sokić, J.,& Sovilj, P.. (2013). ERP korelati placebo i 'anti-placebo' efekata. in Primenjena psihologija Univerzitet u Novom Sadu - Filozofski fakultet - Odsek za psihologiju, Novi Sad., 6(4), 339-354. https://hdl.handle.net/21.15107/rcub_reff_1711
Biro M, Ković V, Novović Z, Pejović J, Sokić J, Sovilj P. ERP korelati placebo i 'anti-placebo' efekata. in Primenjena psihologija. 2013;6(4):339-354. https://hdl.handle.net/21.15107/rcub_reff_1711 .
Biro, Mikloš, Ković, Vanja, Novović, Zdenka, Pejović, Jovana, Sokić, Jelena, Sovilj, Platon, "ERP korelati placebo i 'anti-placebo' efekata" in Primenjena psihologija, 6, no. 4 (2013):339-354, https://hdl.handle.net/21.15107/rcub_reff_1711 .
Related items
Showing items related by title, author, creator and subject.
-
Measurement of event-related potentials and placebo
Sovilj, Platon; Ković, Vanja; Biro, Mikloš; Radak, Marin; Mitrović, Zoran (Univerzitet u Kragujevcu - Fakultet tehničkih nauka, Čačak, 2014) -
Blinding in tDCS Studies: Correct End-of-Study Guess Does Not Moderate the Effects on Associative and Working Memory
Stanković, Marija; Živanović, Marko; Bjekić, Jovana; Filipović, Saša R. (Basel : MDPI, 2022) -
No evidence of tDCS placebo-effect on associative and working memory performance in healthy adults
Stanković, Marija; Bjekić, Jovana; Živanović, Marko; Filipović, Saša R. (Book of abstracts - International scientific conference 25th Ramiro and Zoran Bujas days, 2021)